Prostate cancer — all decisions

The Board remands the claims for an increased rating and earlier effective date for the Veteran's heart disability, an increased rating for prostate cancer, SMC based on the need for aid and attendance, and a TDIU due to inadequate VA examinations.

The Board remands the claims for service connection for residuals of prostate cancer, arthrosclerosis (claimed as a heart condition), allergic rhinitis, depressive disorder, and complex partial seizures evolving to generalized seizure due to incomplete service treatment records and the need for additional evidence regarding in-service herbicide exposure.

The Veteran is granted special monthly compensation based on the need for aid and attendance from November 20, 2019.

The Board denied the veteran's claims for increased ratings for hypertension, prostate cancer, and erectile dysfunction.

The Board remands the claims for a rating in excess of 20 percent for diabetes mellitus, type II and prostate cancer, service connection for osteoarthritis of both knees, pseudophakia (claimed as vision), and entitlement to TDIU due to pre-decisional duty to assist errors.

The Veteran's service-connected prostate cancer alone has rendered him unable to secure and follow a substantially gainful occupation, warranting a total disability rating based on individual unemployability.

The Veteran's service-connected prostate cancer is granted a 100 percent disability rating and special monthly compensation at the housebound rate, effective June 1, 2024.

The Board remands the issues of service connection for diabetes mellitus, hypertension, erectile dysfunction, and residuals of prostate cancer due to further development needed regarding exposure to non-herbicide agent contaminants at Fort Dix.

The Board denied service connection for soft tissue sarcoma of the right wrist, to include as due to exposure to contaminated water at Camp Lejeune, and an initial rating in excess of 10 percent for bilateral hearing loss. The claims for service connection for prostate cancer and sleep apnea were remanded.

The Board remands the claims for further evidentiary development and to obtain additional medical opinions.

The Board granted service connection for diabetes mellitus type II, hypertension, and prostate cancer on a direct basis, effective August 10, 2022.

The Board remands the claims for service connection for glaucoma and prostate cancer due to duty to assist errors, including inadequate medical nexus opinions and missing private treatment records.

The Board denied service connection for a heart disorder and prostate cancer as the evidence did not support a finding that these conditions were related to the Veteran's military service, including asbestos exposure.

The Veteran's claim for presumptive service connection for prostate cancer from August 10, 2022, was granted based on the PACT Act. The issue of direct service connection remains pending.

The Board granted service connection for an acquired psychiatric disorder, but denied service connection for high cholesterol and other conditions.,The Board denied service connection for high cholesterol and other conditions.

The Board denied earlier effective dates for service connection and increased ratings, finding no evidence of formal or informal claims prior to the specified dates.

The appeal was dismissed due to the Veteran's death during its pendency.

The Board remands the claims for service connection due to inadequate opinions addressing in-service exposure to lead, asbestos, microwave, and radiofrequency.

The Board granted service connection for prostate cancer, finding a relationship between the Veteran's condition and his MOS as an Operating Room Specialist.

The Board remands the claim for compensation under 38 U.S.C. § 1151 for prostate cancer due to an inadequate VA examination and missing private medical records.